Intervention not reportedRelapse rate 16 weeks of treatment · children/youth with ASD1 finding from 1 reviewAripiprazole for autism spectrum disorders (ASD) 2016 · Cochrane Headline outcomes onlyno estimate extracted1 study · 85 participantsLow